Carisoprodol tolerance and precipitated withdrawal

Drug and Alcohol Dependence

Volumn 123, Issue 1-3, 2012, Pages 29-34

  Gatch, Michael B ^a   Nguyen, Jacques D ^a   Carbonaro, Theresa ^a   Forster, Michael J ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Barbiturate site; Bemegride; Benzodiazepine site; Carisoprodol; Flumazenil; GABAa receptorl; Mouse; Precipitated withdrawal; Tolerance

Indexed keywords

BEMEGRIDE; CARISOPRODOL; FLUMAZENIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY POSTURE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EXPOSURE; DRUG TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIGHTING REFLEX; STARTLE REFLEX; TREMOR; WITHDRAWAL SYNDROME;

ANIMALS; BEMEGRIDE; CARISOPRODOL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FLUMAZENIL; GABA MODULATORS; MALE; MICE; MUSCLE RELAXANTS, CENTRAL; PHYSICAL STIMULATION; POSTURE; STARTLE REACTION; SUBSTANCE WITHDRAWAL SYNDROME; TREMOR;

MUS;

EID: 84861224220     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.10.010     Document Type: Article

References (35)

1. Bailey D.N., Briggs J.R. Carisoprodol: an unrecognized drug of abuse. Am. J. Clin. Pathol. 2002, 117:396-400.
2. Balster R.L. Drug abuse potential evaluation in animals. Brit. J. Addiction 1991, 86:1549-1558.
3. Bramness J.G., Mørland J., Sørlid H.K., Rudberg N., Jacobse D. Carisoprodol intoxications and serotonergic features. Clin. Toxicol. (Phila.) 2005, 43:39-45.
4. Bramness J.G., Skurtveit S., Morland J. Impairment due to intake of carisoprodol. Drug Alcohol Depend. 2004, 74:311-318.
5. Colpaert F.C. Effects of putative a-adrenoceptor antagonists and of other compounds on the loss of the righting reflex and on exophtalmia induced by zylazine in rat. Drug Dev. Res. 1986, 7:221-239.
6. De Vry J., Slangen J.L. Differential interactions between chlordiazepoxide, pentobarbital and benzodiazepine antagonists Ro 15-1788 and CGS 8216 in a drug discrimination procedure. Pharmacol. Biochem. Behav. 1986, 24:999-1005.
7. Eddy N.B. Codeine and its alternates for pain and cough relief. Ann. Intern. Med. 1969, 71:1209-1212.
8. Eleid M.F., Krahn L.E., Agrwal N., Goodman B.P. Carisoprodol withdrawal after internet purchase. Neurologist 2010, 16:262-264.
9. Emmett-Oglesby M.W., Mathis D.A., Harris C.M., Idemudia S.O., Lal H. Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol. J. Pharmacol. Exp. Ther. 1988, 244:892-897.
10. Fass J.A. Carisoprodol legal status and patterns of abuse. Ann. Pharmacother. 2010, 44:1962-1967.
11. France C.P., Gerak L.R., Rowlett J.K., Woolverton W.L., Winger G., Briscoe R.J. Progress report from the testing program for stimulant and depressant drugs (1998). NIDA Research Monograph 180: Problems of Drug Dependence, 1999: Proceedings of the 61st Annual Scientific Meeting 1999, 423-433. The College on Problems of Drug Dependence, Inc., U.S. Department of Health and Human Services, Government Printing Office, Washington, D.C. L.S. Harris (Ed.).
12. Fraser H.F., Essig C.F., Wolbach A.B. Evaluation of carisoprodol and phenyramidol for addictiveness. UNODC Bull. Narc. 1961, 1-5.
13. Gatch M.B., Wallis C.J., Lal H. Effects of ritanserin on ethanol withdrawal-induced anxiety in rats. Alcohol 2000, 21:11-17.
14. Goldstein D.B. Relationship of alcohol dose to intensity of withdrawal signs in mice. J. Pharmacol. Exp. Ther. 1972, 180:203-215.
15. Gonzalez L.A., Gatch M.B., Taylor C.M., Bell-Horner C.L., Forster M.J., Dillon G.H. Carisoprodol-mediated modulation of GABAA receptors: in vitro and in vivo studies. J. Pharmacol. Exp. Ther. 2009, 329:827-837.
16. Harvey S.C. Hypnotics and sedatives. Pharmacological Basis of Therapeutics 1985, 339-371. Macmillan Publishing, New York. A.G. Gilman, L.S. Goodman, T.W. Rall, F. Murad (Eds.).
17. Heacock C., Bauer M.S. Tolerance and dependence risk with the use of carisoprodol. Am. Fam. Physician 2004, 69:1622-1623.
18. Herling S., Shannon H.E. Ro 15-1788 antagonizes the discriminative stimulus effects of diazepam in rats but not similar effects of pentobarbital. Life Sci. 1982, 31:2105-2112.
19. Hoiseth G., Karinen R., Sorlid H.K., Bramness J.G. The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug. Basic Clin. Pharmacol. Toxicol. 2009, 105:345-349.
20. Institute of Laboratory Animal Resources Guidelines for the care and use of mammals in neuroscience and behavioral research 1996, National Academies Press, Washington, DC.
21. Littrell R.A., Sage T., Miller W. Meprobamate dependence secondary to carisoprodol (Soma) use. Am. J. Drug Alcohol Abuse 1993, 19:133-134.
22. Luo X., Pietrobon R., Curtis L.H., Hey L.A. Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States. Spine (Phila, Pa 1976) 1976, 29:E531-E537.
23. Morse R.M., Chua L. Carisoprodol dependence: a case report. Am. J. Drug Alcohol Abuse 1978, 5:527-530.
24. Nakamura H., Shimizu M. Physical dependence on meprobamate after repeated oral administration in rats. Jpn. J. Pharmacol. 1983, 33:1171-1176.
25. National Toxicology Program NTP technical report on the toxicity studies of carisoprodol (CAS No. 78-44-4) administered by gavage to F344/N rats and B6C3F1 mice. Toxicol. Rep. Ser. 2000, 1-14.
26. Olsen H., Koppang E., Alvan G., Mørland J. Carisoprodol elimination in humans. Ther. Drug Monit. 1994, 16:337-340.
27. Reeves R.R., Beddingfield J.J., Mack J.E. Carisoprodol withdrawal syndrome. Pharmacotherapy 2004, 24:1804-1806.
28. Reeves R.R., Burke R.S. Carisoprodol: abuse potential and withdrawal syndrome. Curr. Drug Abuse Rev. 2010, 3:33-38.
29. Rohatgi G., Rissmiller D.J., Gorman J.M. Treatment of carisoprodol dependence: a case report. J. Psychiatr. Pract. 2005, 11:347-352.
30. Schechter M.D. Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 1984, 8:359-364.
31. Substance Abuse and Mental Health Services Administration Summary of Findings from the 2000 National Household Survey on Drug Abuse 2001, Office of Applied Studies, NHSDA Series H-13, DHHS Publication No. (SMA) 01-3549, Rockville, MD.
32. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, 2011. Drug Abuse WarningNetwork, 2008: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD.
33. Woods J., Katz J., Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol. Rev. 1992, 44:151-347.
34. Yutrzenka G.J. Intensity of the withdrawal syndrome varies with duration of pentobarbital administration. Pharmacol. Biochem. Behav. 1989, 34:49-51.
35. Yutrzenka G.J., Stone T., Anderson S. Ro 15-4513 alteration of pentobarbital dependence. Pharmacol. Biochem. Behav. 1996, 55:379-386.